Cancer drug shortages prompt NPPA to raise prices of key medicines, vaccines
NEW DELHI: Amid concerns over shortages of two critical cancer medicines, the National Pharmaceutical Pricing Authority (NPPA) has approved a 50% hike in the ceiling prices of Carboplatin and Cisplatin injections, citing escalating raw material costs and supply concerns. The regulator has also revised prices of anti-tetanus immunoglobulin and three key childhood vaccines to ensure…
